CorMedix, Inc. to Announce Third Quarter 2014 Results on November 13, 2014; Conference call hosted at 9 am on Friday, November 14, 2014

BRIDGEWATER, N.J., Nov. 6, 2014 /PRNewswire/ -- CorMedix Inc. ("CorMedix") (NYSE MKT: CRMD), a specialty pharmaceutical company focused on developing and commercializing therapeutic products for the treatment of infectious diseases in both acute and chronic care settings, today announced that a conference call will be held on Friday, November 14, 2014 at 9:00 a.m. ET to discuss the Company's third quarter 2014 results.  Randy Milby, Chief Executive Officer of CorMedix, will host the call. The third quarter 2014 financial results will be issued at approximately 4:00 PM Eastern time on November 13^th.

In order to participate in the conference call, dial:

(Toll Free): 877-407-8031 or (International): 201-689-8031.
Please reference: CorMedix Conference.

To listen to a recording of the call:

Replay Number (Toll Free): 1-877-660-6853
Replay Number (International): 1-201-612-7415
Conference ID #: 13595374
Teleconference Replay Available Until: Nov 21, 2014 at 11:59 PM

About CorMedix
CorMedix Inc. is a commercial-stage pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the prevention and treatment of cardiac, renal and infectious diseases. CorMedix's first commercial product is Neutrolin®, approved in the European Union as a catheter lock solution for the prevention of catheter related bloodstream infections and maintenance of catheter patency in tunneled, cuffed, central venous catheters used for vascular access in patients who are receiving hemodialysis as well as patients being administered total parenteral nutrition (TPN), chemotherapy, IV fluids or are in the ICU receiving IV critical care medications. Please see the company's website at www.cormedix.com for additional information.

Logo - http://photos.prnewswire.com/prnh/20130715/NY47431LOGO

SOURCE CorMedix Inc.

Related Links

http://www.cormedix.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED